Syncom Formulations (India) Limited (NSE:SYNCOMF)
India · Delayed Price · Currency is INR 13.22
-0.35 (-2.58%)
Jul 22, 2026, 3:29 PM IST
NSE:SYNCOMF Market Cap
NSE:SYNCOMF has a market cap or net worth of 12.74 billion as of July 22, 2026. Its market cap has decreased by -27.81% in one year.
Market Cap
12.74B
Enterprise Value
11.62B
Revenue
4.89B
Ranking
n/a
PE Ratio
16.66
Stock Price
13.22
ChartMarket Cap Chart
Since December 31, 2001, NSE:SYNCOMF's market cap has increased from 267.05M to 12.74B, an increase of 4,669.55%. That is a compound annual growth rate of 17.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 12.74B | -5.05% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 49.90B |
| Solara Active Pharma Sciences | 26.92B |
| Beta Drugs | 24.62B |
| Indoco Remedies | 22.57B |
| Ind-Swift Laboratories | 20.29B |
| Sakar Healthcare | 20.00B |
| Windlas Biotech | 17.99B |
| Jagsonpal Pharmaceuticals | 14.97B |